Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170

1.

Endogenous steroid hormones in hair: investigations on different hair types, pigmentation effects and correlation to nails.

Daniela Voegel C, Hofmann M, Kraemer T, Baumgartner MR, Maria Binz T.

Steroids. 2019 Dec 3:108547. doi: 10.1016/j.steroids.2019.108547. [Epub ahead of print]

PMID:
31809760
2.

Analytical considerations for postmortem metabolomics using GC-high-resolution MS.

Brockbals L, Kraemer T, Steuer AE.

Anal Bioanal Chem. 2019 Nov 22. doi: 10.1007/s00216-019-02258-3. [Epub ahead of print]

PMID:
31758199
3.

A possible new oxidation marker for hair adulteration: detection of PTeCA (1H-pyrrole-2,3,4,5-tetracarboxylic acid) in bleached hair.

Eisenbeiss L, Binz TM, Baumgartner MR, Steuer AE, Kraemer T.

Drug Test Anal. 2019 Oct 26. doi: 10.1002/dta.2713. [Epub ahead of print]

PMID:
31655024
4.

Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers.

Dornbierer DA, Boxler M, Voegel CD, Stucky B, Steuer AE, Binz TM, Baumgartner MR, Baur DM, Quednow BB, Kraemer T, Seifritz E, Landolt HP, Bosch OG.

Int J Neuropsychopharmacol. 2019 Oct 1;22(10):631-639. doi: 10.1093/ijnp/pyz047.

5.

Stroke in malignancy: complexities of diagnosis and management: a case report.

Siriratnam P, Kraemer T, Sahathevan R.

J Med Case Rep. 2019 Aug 20;13(1):260. doi: 10.1186/s13256-019-2183-8.

6.

Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.

Staeheli SN, Veloso VP, Bovens M, Bissig C, Kraemer T, Poetzsch M.

Drug Test Anal. 2019 Sep;11(9):1369-1376. doi: 10.1002/dta.2664. Epub 2019 Aug 19.

PMID:
31219237
7.

Prevalence and risk factors of ischemic stroke in the young; a regional Australian perspective.

Siriratnam P, Godfrey A, O'Connor E, Pearce D, Hu CC, Low A, Hair C, Oqueli E, Sharma A, Kraemer T, Sahathevan R.

Intern Med J. 2019 Jun 18. doi: 10.1111/imj.14407. [Epub ahead of print]

PMID:
31211881
8.

Metabolomic Strategies in Biomarker Research-New Approach for Indirect Identification of Drug Consumption and Sample Manipulation in Clinical and Forensic Toxicology?

Steuer AE, Brockbals L, Kraemer T.

Front Chem. 2019 May 10;7:319. doi: 10.3389/fchem.2019.00319. eCollection 2019. Review.

9.

(Un)targeted hair metabolomics: first considerations and systematic evaluation on the impact of sample preparation.

Eisenbeiss L, Steuer AE, Binz TM, Baumgartner MR, Kraemer T.

Anal Bioanal Chem. 2019 Jul;411(17):3963-3977. doi: 10.1007/s00216-019-01873-4. Epub 2019 May 23.

PMID:
31123781
10.

Neurophysiological signature of gamma-hydroxybutyrate augmented sleep in male healthy volunteers may reflect biomimetic sleep enhancement: a randomized controlled trial.

Dornbierer DA, Baur DM, Stucky B, Quednow BB, Kraemer T, Seifritz E, Bosch OG, Landolt HP.

Neuropsychopharmacology. 2019 Oct;44(11):1985-1993. doi: 10.1038/s41386-019-0382-z. Epub 2019 Apr 8.

PMID:
30959514
11.

Cocaine Hydroxy Metabolites in Hair: Indicators for Cocaine Use Versus External Contamination☆.

Scholz C, Quednow BB, Herdener M, Kraemer T, Baumgartner MR.

J Anal Toxicol. 2019 Aug 23;43(7):543-552. doi: 10.1093/jat/bkz022.

PMID:
30927360
12.

Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.

Pump WC, Kraemer T, Huyton T, Hò GT, Blasczyk R, Bade-Doeding C.

Int J Mol Sci. 2019 Mar 22;20(6). pii: E1454. doi: 10.3390/ijms20061454.

13.

In situ postmortem ethanol quantification in the cerebrospinal fluid by non-water-suppressed proton MRS.

Zoelch N, Hock A, Steuer AE, Heimer J, Kraemer T, Thali MJ, Gascho D.

NMR Biomed. 2019 May;32(5):e4081. doi: 10.1002/nbm.4081. Epub 2019 Mar 5.

PMID:
30835926
14.
15.

Measuring the accuracy of propofol target-controlled infusion (TCI) before and after surgery with major blood loss.

Mohler T, Welter J, Steurer M, Neumann L, Zueger M, Kraemer T, Dullenkopf A.

J Clin Monit Comput. 2019 Jan 22. doi: 10.1007/s10877-019-00261-8. [Epub ahead of print]

PMID:
30671895
16.

Identification of new urinary gamma-hydroxybutyric acid markers applying untargeted metabolomics analysis following placebo-controlled administration to humans.

Steuer AE, Raeber J, Steuer C, Boxler MI, Dornbierer DA, Bosch OG, Quednow BB, Seifritz E, Kraemer T.

Drug Test Anal. 2019 Jun;11(6):813-823. doi: 10.1002/dta.2558. Epub 2019 Jan 16.

PMID:
30548573
17.

Fatal poisoning involving cyclopropylfentanyl - Investigation of time-dependent postmortem redistribution.

Brockbals L, Staeheli SN, Gentile S, Schlaepfer M, Bissig C, Bolliger SA, Kraemer T, Steuer AE.

Forensic Sci Int. 2019 Jan;294:80-85. doi: 10.1016/j.forsciint.2018.11.007. Epub 2018 Nov 16.

PMID:
30497048
18.

Identification of urinary metabolites of the synthetic cannabinoid 5F-CUMYL-P7AICA in human casework.

Staeheli SN, Steuer AE, Kraemer T.

Forensic Sci Int. 2019 Jan;294:76-79. doi: 10.1016/j.forsciint.2018.11.002. Epub 2018 Nov 13.

PMID:
30471536
19.

Analytical considerations for (un)-targeted metabolomic studies with special focus on forensic applications.

Boxler MI, Schneider TD, Kraemer T, Steuer AE.

Drug Test Anal. 2019 May;11(5):678-696. doi: 10.1002/dta.2540. Epub 2018 Nov 28.

PMID:
30408838
20.

Evaluation of endogenous urinary biomarkers for indirect detection of urine adulteration attempts by five different chemical adulterants in mass spectrometry methods.

Steuer AE, Kamber D, Kraemer T.

Drug Test Anal. 2019 May;11(5):638-648. doi: 10.1002/dta.2539. Epub 2018 Nov 28.

PMID:
30408836

Supplemental Content

Loading ...
Support Center